Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank14
Year-over-Year Change
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P14
Within normal range
Average
36.79%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | -99.79% |
| Q3 2024 | 936.17% |
| Q2 2024 | 0.00% |
| Q1 2024 | 176.47% |
| Q4 2023 | -66.67% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |